Neurodegenerative Disease Drug Discovery: UCSF and Genentech
UCSF enters drug discovery agreement with Genentech
Posted February 19, 2010
"The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.
"Through the agreement, Genentech will provide funding and its research acumen in neuroscience and will collaborate with UCSF to identify small molecules."
Read the full article